MentionFox
Home › funding signals › Indee Labs
Accelerator · announced

Indee Labs (YC W17) — Enabling T cell immunotherapy discovery, development and manufacturing

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Indee Labs is a Y Combinator company in the Winter 2017 batch. Its directory entry describes it as: Enabling T cell immunotherapy discovery, development and manufacturing. The founder listed is Ryan Pawell (Founder/CEO) (Y Combinator directory entry, December 15, 2016).

6 more companies from YC Winter 2017 ↓

Run the free check on Indee Labs →

Sell to companies like Indee Labs? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Indee Labs

New accelerator entry · 2016-12-15 · the record

Winter 2017
batch
5
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2017
Announced2016-12-15
StageEarly
StatusActive
Team size5
IndustryHealthcare
Sub-industryHealthcare -> Drug Discovery and Delivery
SectorsGene Therapy, Microfluidics, Cell Therapy
RegionsUnited States of America, America / Canada, Remote, Partly Remote
BasedSan Francisco
HiringNo
Sitehttp://www.indeelabs.com
Founded2015

Pitching, partnering or investing alongside them? See who really runs and owns Indee Labs.

Free to see. No signup.

Keep reading

More on Indee Labs and the records around it.

Also in YC Winter 2017

Same batch, Healthcare first.

What do you want to do with Indee Labs?

Get the full cited report on Indee Labs

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Indee Labs: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Want the whole picture on Indee Labs?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Indee Labs: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Indee Labs covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Indee Labs: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Indee Labs. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups Manufacturing and industrial startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Indee Labs: Accepted into Y Combinator Winter 2017
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-indee-labs
Last updated 2026-10-27
Primary record: Y Combinator directory entry
Indee Labs (YC W17) — Enabling T cell immunotherapy discovery, development and manufacturing. MentionFox, 2026-10-27. https://mentionfox.com/funding/yc-indee-labs